Drug diversion and abuse in the veterinary setting
Management of controlled substances in veterinary medicine changed with the onset of the opioid epidemic, which has continued to grow in scale and complexity. Today, veterinarians face increased risks of drug diversion in our practices, along with rising rates of substance abuse and addiction among veterinary professionals.
In this webinar, participants will gain a foundational understanding of drug diversion and the various ways it can occur in the veterinary setting. You’ll discover how to recognize and proactively address suspected or confirmed drug diversion; individual responsibilities for reporting; the importance of recordkeeping; and effective ways to navigate situations involving diversion, substance abuse, and addiction.
This webinar may assist in meeting state CE requirements for prescribing controlled substances.
LEARNING OBJECTIVES:
- Identify signs of drug diversion and the various ways it can occur in the veterinary profession.
- Explore strategies to proactively address suspected or confirmed drug diversion, including individual responsibilities for reporting.
- Discover effective ways to respond to situations involving individuals suffering from substance abuse or addiction.
|
Peter Weinstein, DVM, MBA Dr. Peter Weinstein teaches business and finance at Western University College of Veterinary Medicine. For more than 20 years, he has been providing small-business and corporate consulting services to veterinary practices nationwide. He has served as executive director and president of the Southern California Veterinary Medical Association (SCVMA), and is a past president of the California Veterinary Medical Association. He also was president of VetPartners, a nonprofit association for veterinary business specialists. Dr. Weinstein speaks and writes extensively on practice management, team building, leadership, collegiality, marketing, and other topics focused on improving veterinary practices. He co-authored with Michael E. Gerber “The E-Myth Veterinarian—Why Most Veterinary Practices Don’t Work and What to Do About It.” He received his DVM from the University of Illinois and earned a master’s degree in business administration from the University of Redlands while managing his own practice and practicing veterinary medicine full time. |
|
Kelley Detweiler Kelley Detweiler is a leader in DEA regulations, controlled substances, and the precursor chemicals used to manufacture them. With experience in the pharmaceutical, supply chain, manufacturing, and human healthcare industries, she now focuses her expertise on supporting the veterinary profession and reducing the risk of dangerous drug diversion in our communities. Through her companies, DEA360 and Kolibry, and her partnership with Dr. Peter Weinstein in Simple Solutions for Vets, she helps veterinary professionals navigate controlled substance and regulatory issues. Her work includes consulting, regulatory support, standard operating procedure development, education, and training. She also is a speaker and educator for various organizations and institutions. She has visited over 850 veterinary practices nationwide and understands the unique needs, concerns, and challenges facing the veterinary profession. Detweiler writes the “Let’s Talk Drugs” column in Today’s Veterinary Business and she is the co-author of “Safeguarding Controlled Substances,” published by the American Animal Hospital Association. When she is not putting out regulatory fires, she is a proud parent of two kids, a pet owner, and philanthropist. |
